J Korean Acad Child Adolesc Psychiatry.
2012 Oct;23(Suppl):S46-S54.
Treatment of Comorbid Anxiety and Mood Disorder in ADHD
- Affiliations
-
- 1Department of Psychiatry, Inje University College of Medicine, Ilsan Paik Hospital, Goyang, Korea.
- 2Department of Psychiatry, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
- 3Seoul Psychiatric Clinic, Seoul, Korea.
- 4Department of Psychiatry, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
- 5Department of Psychiatry, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, Korea.
- 6Department of Psychiatry, Jeju National University Hosptital, Jeju National University College of Medicine, Jeju, Korea. yskypy@cheju.ac.kr
Abstract
- Anxiety and mood disorders are frequently comorbid with attention-deficit/hyperactivity disorder (ADHD). In this report, the characteristics of anxiety and mood disorder [major depressive disorder (MDD) and bipolar disorder] were investigated in an attempt to identify differences that could potentially advance our understanding of treatment options for these comorbidities with ADHD. We reviewed studies which examined stimulant response in children diagnosed with ADHD/anxiety, depression and bipolar disorder. Recent research suggests that stimulants can be safely used in children with anxiety/depressive disorder comorbid with ADHD. Antidepressants may be used in conjunction with stimulants to treat MDD and anxiety, while mood stabilizers and atypical antipsychotics are often required to treat manic symptoms. After resolution of the comorbid manic episode, stimulant treatment of ADHD may be safely undertaken. Clinicians should be prepared to deal with a wide range of emotional problems beyond the core symptoms of ADHD.